Álvaro T. G.
- Country
- Spain
- Department
- Oncology department
Research Overview
- Efficacy and Safety of Atezolizumab Versus Best Supportive Care Post-Adjuvant Cisplatin-Based Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer
- Phase 3 Randomized Double-Blind Trial of Ociperlimab and Tislelizumab vs. Pembrolizumab in PD-L1-Selected Advanced Non-Small Cell Lung Cancer
- A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects with TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy
Data & Insights
Has run more than one trial at 28 of 181 partner sites.
Specializations
Advanced Solid Tumor Oncology
Focused on therapeutic strategies for metastatic and treatment‑resistant solid cancers.
- metastatic breast cancer
- non‑small cell lung cancer
- renal cell carcinoma
- colorectal cancer
- ovarian cancer
Clinical investigations are conducted at Hospital Del Mar, integrating precision‑medicine approaches.
Hematologic Malignancies
Research dedicated to blood‑derived cancers and their molecular drivers.
- acute myeloid leukemia
- chronic lymphocytic leukemia
- multiple myeloma
- myelodysplastic syndrome
- Hodgkin lymphoma
Efforts emphasize novel targeted agents and immunotherapeutic combinations.
Autoimmune and Inflammatory Disorders
Investigation of immune‑mediated diseases affecting skin, joints, and systemic organs.
- systemic lupus erythematosus
- psoriasis
- atopic dermatitis
- hidradenitis suppurativa
- immune thrombocytopenia
Trials explore biologic modulators and pathway‑specific inhibitors.
Infectious and Pulmonary Diseases
Targeted studies on respiratory infections and related complications.
- nontuberculous mycobacterial lung infection
- COVID-19
- hospital‑acquired pneumonia
- bronchiectasis
- invasive candidiasis
Research integrates antimicrobial stewardship with host‑response assessments.
Cardiovascular and Metabolic Conditions
Clinical focus on acute and chronic heart diseases and metabolic risk factors.
- acute coronary syndrome
- heart failure
- atrial fibrillation
- atherosclerotic cardiovascular disease
- hypercholesterolemia
Investigations aim to reduce cardiovascular events through innovative therapeutics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.